ORCL three-lens brief
Evidence-based stock research on ORCL. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $243.71 — 41% above current (38 analysts). · Negative free cash flow last quarterly (-$22.30B).
- Analyst mean target $243.71 — 41% above current (38 analysts).
- Negative free cash flow last quarterly (-$22.30B).
- Debt-to-equity of 415.3 — balance-sheet-heavy.
ORCL closed at $173.28 (-1.70%) as of 2026-04-25. Market cap: $498.36B. P/E (trailing) 31.2. Positives: analyst mean target $243.71 — 41% above current (38 analysts).. Concerns: negative free cash flow last quarterly (-$22.30B).; debt-to-equity of 415.3 — balance-sheet-heavy.. Last quarter: Revenue $17.19B, net income $3.70B, free cash flow -$22.30B.
Why three lenses on ORCL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ORCLacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ORCL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ORCL brief"></iframe>